Advancing More Equitable Human Services Policies and Programs
Explore how AIR—with our partners, government leaders, and field experts—is advancing equity in human services programs and policies in the areas of education, social justice, and the workforce.
Methods of Synthesis and Integration Center (MOSAIC)
MOSAIC experts are committed to conducting high quality research synthesis, improving research synthesis methods, and promoting the use and uptake of reviews and meta-analyses.
Our mission is to generate and use rigorous evidence that contributes to a better, more equitable world.
Learn about our values, our history, and our commitment to diversity, equity, and inclusion.
AIR Equity Initiative
AIR is making a five-year, $100M+ investment in behavioral and social science research and technical assistance to address the underlying causes of systemic inequities and increase opportunities for people and communities.
LEARN MORE ABOUT THE INITIATIVE
READ THE EQUITY INITIATIVE'S ANNUAL REPORT (2021-22)
Spotlight on Our Work
Research & Program Evaluation
AIR conducts rigorous research and evaluations that provide important information about the effectiveness of programs and policies in the U.S. and across the globe.
We work shoulder-to-shoulder with clients to help them build capacity and transform systems to achieve better outcomes for those they serve.
Data Science and Technology
AIR uses data and technology to help our clients and communities identify challenges, find solutions, and make information usable and easily accessible.
Survey Design and Administration
Our experts can help government agencies and organizations develop, administer, and analyze surveys that create reliable, actionable data.
Research Insights on Health Equity for Afghan Refugees
Backed by the AIR Equity Initiative, AIR is working with partners to help multisector organizations collaborate more effectively and advance health equity for Afghan refugees. In this Q&A, AIR researchers Trenita Childers and Maliha Ali share early insights from the Health Equity for Afghan Refugees (HEAR) project in the District of Columbia, Maryland, and Virginia region.
Could Biosimilars Help Rein in Prescription Drug Costs?
Biologics are innovative therapies for people with debilitating and life-threatening diseases, but these drugs are expensive. In this Q&A, Thiyagu Rajakannan explains how lower-cost versions of these drugs and promising market, regulatory, and policy developments could ease the financial burden.